Speaker: James Baumgartner has spent a majority of his career in pharmaceutical drug discovery and development with a focus on accelerating timelines and success probability for moving drug candidates into human clinical trials. Working for Zymogenetics, a Novo Nordisk Company, and Amgen, James' work resulted in several clinical candidates and 9 patents regarding target discovery and drug development.

As the Senior Technical Director and President of Panlabs, James consulted with over 700 pharmaceutical and biotechnology companies to prioritize clinical candidate pipelines and assist in assessment for clinical development. James has served in a leadership role to lead companies developing novel hemp-based products for the betterment of human and companion pet health.

Currently James leads Panacea Life Sciences, a vertically integrated company that is scientifically driven and medically focused. Panacea Life Sciences is an industry leader developing purposely formulated products and generating clinical data to help provide consumers improved guidance regarding the utility of hemp-based health products.